Dr. Khalid Matin
Claim this profileVirginia Commonwealth University/Massey Cancer Center
Studies Colorectal Cancer
Studies Colon Cancer
13 reported clinical trials
29 drugs studied
Area of expertise
1Colorectal Cancer
Stage IV
Stage III
dMMR positive
2Colon Cancer
Stage IV
Stage III
dMMR positive
Affiliated Hospitals
Clinical Trials Khalid Matin is currently running
Chemotherapy + Radiation
for Rectal Cancer
This is phase 2 trial of neoadjuvant therapy and short-course radiotherapy in resectable rectal cancer.
Recruiting1 award Phase 215 criteria
Chemotherapy + Bevacizumab + Atezolizumab
for Colorectal Cancer
This phase III trial studies how well combination chemotherapy, bevacizumab, and/or atezolizumab work in treating patients with deficient deoxyribonucleic acid (DNA) mismatch repair colorectal cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as fluorouracil, oxaliplatin, and leucovorin calcium, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Bevacizumab may stop or slow colorectal cancer by blocking the growth of new blood vessels necessary for tumor growth. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving combination chemotherapy, bevacizumab, and atezolizumab may work better in treating patients with colorectal cancer.
Recruiting2 awards Phase 31 criteria
More about Khalid Matin
Clinical Trial Related5 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Khalid Matin has experience with
- Fluorouracil
- Oxaliplatin
- Leucovorin Calcium
- Irinotecan
- Bevacizumab
- Atezolizumab
Breakdown of trials Khalid Matin has run
Colorectal Cancer
Colon Cancer
Cancer
Rectal Cancer
DNA Repair Disorder
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Khalid Matin specialize in?
Khalid Matin focuses on Colorectal Cancer and Colon Cancer. In particular, much of their work with Colorectal Cancer has involved Stage IV patients, or patients who are Stage III.
Is Khalid Matin currently recruiting for clinical trials?
Yes, Khalid Matin is currently recruiting for 6 clinical trials in Richmond Virginia. If you're interested in participating, you should apply.
Are there any treatments that Khalid Matin has studied deeply?
Yes, Khalid Matin has studied treatments such as Fluorouracil, Oxaliplatin, Leucovorin Calcium.
What is the best way to schedule an appointment with Khalid Matin?
Apply for one of the trials that Khalid Matin is conducting.
What is the office address of Khalid Matin?
The office of Khalid Matin is located at: Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia 23298 United States. This is the address for their practice at the Virginia Commonwealth University/Massey Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.